Improved Tolerability and Continued Immunomodulation Among Subjects Aged 4-17 Years Following 12 or 18 Months of Daily Therapeutic AR101 Dosing
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY（2020）
关键词
Medication Adherence
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要